ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Akorn CEO Raj Rai resigns after US court permits Fresenius to exit merger deal
December 10, 2018Commenting on the news, Piper Jaffray analyst David Amsellem remarked that Rai's departure is good news for Akorn, noting that the drugmaker "could benefit from a new leadership team that is better versed in manufacturing operations and generics R&D."
Pharma Sources Insight January 2025
